We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Trypan Blue Versus Brillant Blue for Epiretinal Membranes

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT00757380
First Posted: September 23, 2008
Last Update Posted: January 26, 2016
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by (Responsible Party):
Dr. Christiane I. Falkner-Radler, The Ludwig Boltzmann Institute of Retinology and Biomicroscopic Laser Surgery
  Purpose
Membraneppeling alone versus Membranepeeling with Membrane Limitans Interna Pelling using two different Dyes for Epiretinal Membrane Surgery.

Condition Intervention
Idiopathic Epiretinal Membranes Procedure: Trypan Blue Procedure: Brillant Blue

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Single (Outcomes Assessor)
Primary Purpose: Treatment
Official Title: Membranepeeling With Trypan Blue Versus Membranpeeling With Brillant Blue for Patients With Idiopathic Epiretinal Membranes

Resource links provided by NLM:


Further study details as provided by Dr. Christiane I. Falkner-Radler, The Ludwig Boltzmann Institute of Retinology and Biomicroscopic Laser Surgery:

Primary Outcome Measures:
  • Visual acuity [ Time Frame: 3 months ]

Secondary Outcome Measures:
  • Microperimetry optical coherence tomographie questionnaire (metamorphopsien) [ Time Frame: 3 months ]

Enrollment: 60
Study Start Date: July 2008
Study Completion Date: August 2015
Primary Completion Date: August 2015 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Active Comparator: Group 1
Trypan Blue
Procedure: Trypan Blue
Membranepeeling with TB
Active Comparator: Group 2
Brillant Blue
Procedure: Brillant Blue
Membranepeeling and membrana limitans interna peeling with BB

  Eligibility

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   60 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • Idiopathic eperetinal membranes
  • Phakic or pseudophakic eyes
  • Age over 60 years

Exclusion Criteria:

  • Secondary epiretinal membranes
  • Severe ocular pathologies
  Contacts and Locations
Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00757380


Locations
Austria
The Ludwig Boltzmann Institute of Retinology and Biomicroscopic Laser Surgery
Vienna, Austria, 1030
Sponsors and Collaborators
The Ludwig Boltzmann Institute of Retinology and Biomicroscopic Laser Surgery
Investigators
Study Chair: Katharina Kreppler, Univ. Doz. Dr. The Ludwig Boltzmann Institute of Retinology and Biomicroscopic Laser Surgery
Principal Investigator: Christiane I Falkner-Radler, Dr. The Ludwig Boltzmann Institute of Retinology and Biomicroscopic Laser Surgery
  More Information

Responsible Party: Dr. Christiane I. Falkner-Radler, MD, The Ludwig Boltzmann Institute of Retinology and Biomicroscopic Laser Surgery
ClinicalTrials.gov Identifier: NCT00757380     History of Changes
Other Study ID Numbers: FR-4-CI-2008
First Submitted: September 21, 2008
First Posted: September 23, 2008
Last Update Posted: January 26, 2016
Last Verified: January 2016

Keywords provided by Dr. Christiane I. Falkner-Radler, The Ludwig Boltzmann Institute of Retinology and Biomicroscopic Laser Surgery:
epiretinal membranes
vitreoretinal dyes
membranepeeling

Additional relevant MeSH terms:
Epiretinal Membrane
Retinal Diseases
Eye Diseases
Diminazene aceturate
Antiprotozoal Agents
Antiparasitic Agents
Anti-Infective Agents
Trypanocidal Agents